NFAT Interactions and the CBM-Complex

Total Page:16

File Type:pdf, Size:1020Kb

NFAT Interactions and the CBM-Complex Analysis of T Cell Receptor-Induced Signaling Modules by Mass Spectrometry: NFAT Interactions and the CBM-Complex. InauguralDissertation to obtain the academic degree Doctor rerum naturalium (Dr. rer. nat.) submitted to the Department of Biology, Chemistry and Pharmacy of Freie Universität Berlin by CHRISTIAN GABRIEL from Leipzig, Germany 2016 EIDESSTATTLICHE ERKLÄRUNG Diese Arbeit wurde vom 15.10.2010 bis zum 15.01.2016 am Deutschen Rheuma- Forschungszentrum in der Arbeitsgruppe von Prof. Dr. Ria Baumgrass angefertigt. 1. Gutachter: Prof. Dr. Ria Baumgrass 2. Gutachter: Prof. Dr. Rupert Mutzel Disputation am: 14. April 2016 i EIDESSTATTLICHE ERKLÄRUNG Eidesstattliche Erklärung Hiermit erkläre ich, dass ich die vorliegende Dissertation selbstständig angefertigt habe. Ausgenommen hiervon sind - wie in Kapitel 2 kenntlich gemacht - die massenspektrometrischen und bioinformatischen Analysen, die in enger Kooperation mit den genannten Wissenschaftlern durchgeführt wurden. Diese Arbeit wurde ohne unzulässige Hilfsmittel angefertigt. Ich habe keine als die hier angegebenen Hilfsmittel und Quellen verwendet. Diese Arbeit wurde in gleicher oder ähnlicher Form noch keiner anderen Prüfungsbehörde vorgelegt. ii TABLE OF CONTENTS Table of Contents Eidesstattliche Erklärung ..........................................................................................................................ii Table of Contents .................................................................................................................................... iii 1. Introduction ..................................................................................................................................... 1 1.1. The Role of T Cells in the Immune System .............................................................................. 1 1.2. The Activation of T Cells. ......................................................................................................... 2 T Cell Stimulation in vitro ................................................................................................ 3 1.3. T Cell Receptor Signaling ......................................................................................................... 3 From T Cell Receptor Stimulation to Phospholipase-C Activation .................................. 3 PKCθ Activation Requires Signaling through the Co-Receptor ........................................ 5 Activation of AP1 Family Proteins through the Action of MAP Kinases .......................... 5 The CBM-Complex Governs the Activation of the Canonical NFκB Pathway in T Cells... 6 1.3.4.1. The CBM-Complex and IKK Activation ..................................................................... 6 1.3.4.2. Post-Translational Modifications Regulate the Activity of the CBM-complex ........ 9 1.3.4.3. CBM-Complex Defects Lead to Immunodeficiency or Cancer Development ........ 10 Calcium Signaling Controls the Activation and Function of NFAT ................................. 11 1.3.5.1. Calcium Influx Triggers the Activation of Calcineurin ........................................... 11 1.3.5.2. NFAT Proteins in Health and Disease .................................................................... 12 1.3.5.3. The Family of NFAT Transcription Factors. ............................................................ 12 1.3.5.4. Structure and Regulation of NFAT Activity ............................................................ 15 1.3.5.5. NFAT Function and Its Interaction with the Transcription Factor AP1.................. 16 1.3.5.6. In the Absence of AP1 Activation, NFAT Promotes T Cell Anergy ......................... 17 1.3.5.7. Interaction of NFAT with Further Transcription Factors ....................................... 18 1.4. Mass Spectrometry to Investigate Protein Complexes ......................................................... 20 MS in Proteomics: Isotope Labeling .............................................................................. 20 Analysis of Protein Complexes by CoIP-MS ................................................................... 22 1.5. The Jurkat Cell Line ................................................................................................................ 24 1.6. Goals of this Thesis ................................................................................................................ 25 2. Material and Methods ................................................................................................................... 26 2.1. Material ................................................................................................................................. 26 Cells ............................................................................................................................... 26 SILAC Media ................................................................................................................... 26 Vectors and Constructs ................................................................................................. 26 Chemicals, Including Peptides and Proteins .................................................................. 28 Pre-made Buffers, Solutions and Stocks ....................................................................... 29 iii TABLE OF CONTENTS Home-made Buffers and Media .................................................................................... 30 Enzymes ......................................................................................................................... 31 Kits ................................................................................................................................. 32 Antibodies...................................................................................................................... 32 Disposables .................................................................................................................... 33 Hardware ....................................................................................................................... 33 Software ........................................................................................................................ 34 2.2. Methods ................................................................................................................................ 34 Methods in Cell Biology ................................................................................................. 34 2.2.1.1. Cell Stimulation ..................................................................................................... 34 2.2.1.2. SILAC Labeling of Jurkat Cells ................................................................................ 34 2.2.1.3. Nucleofection ........................................................................................................ 34 2.2.1.4. Virus Production .................................................................................................... 35 2.2.1.5. Establishment of Stably Transduced Cell Lines by Retroviral Transduction .......... 35 2.2.1.6. Establishment of Stable Transduced Cell Lines by Nucleofection/Selection ........ 35 2.2.1.7. Establishment of Knock-out Cell Lines by CRISPR/CAS9 ........................................ 35 2.2.1.8. Proximity Ligation Assay ........................................................................................ 36 Methods in Protein Biochemistry .................................................................................. 38 2.2.2.1. SDS-PAGE/ Western Blot ....................................................................................... 38 2.2.2.2. Co-Immunopurification ......................................................................................... 39 BCL10 Experiments ................................................................................................................ 39 NFAT Experiments ................................................................................................................. 40 2.2.2.3. MS Measurement .................................................................................................. 41 Bioinformatic Methods.................................................................................................. 41 2.2.3.1. Identification of Peak Regions from Public ChIP-Seq Datasets ............................. 41 2.2.3.2. Identification of Transcription Factor Binding Site Enrichment ............................ 41 2.2.3.3. Identification of Pairs of Transcription Factor Binding Sites ................................. 42 3. Results ........................................................................................................................................... 43 3.1. Characterization of the CBM-complex by Mass Spectrometry ............................................. 43 Generation of a Cell Line that Stably Expresses Epitope-Tagged BCL10 ....................... 43 Isolation of the CBM-Complex via Epitope-Tagged BCL10 ............................................ 44 Isotope Labeling of Jurkat Cells using SILAC .................................................................. 45 Mass Spectrometric Analysis of BCL10 Containing Protein Complexes ........................ 46 TRAF2 and HOIP Interact with BCL10 after TCR Stimulation......................................... 49 3.2. Identification of NFAT Interaction Partners .......................................................................... 52 Establishment of Cell Lines
Recommended publications
  • Table S1. List of Proteins in the BAHD1 Interactome
    Table S1. List of proteins in the BAHD1 interactome BAHD1 nuclear partners found in this work yeast two-hybrid screen Name Description Function Reference (a) Chromatin adapters HP1α (CBX5) chromobox homolog 5 (HP1 alpha) Binds histone H3 methylated on lysine 9 and chromatin-associated proteins (20-23) HP1β (CBX1) chromobox homolog 1 (HP1 beta) Binds histone H3 methylated on lysine 9 and chromatin-associated proteins HP1γ (CBX3) chromobox homolog 3 (HP1 gamma) Binds histone H3 methylated on lysine 9 and chromatin-associated proteins MBD1 methyl-CpG binding domain protein 1 Binds methylated CpG dinucleotide and chromatin-associated proteins (22, 24-26) Chromatin modification enzymes CHD1 chromodomain helicase DNA binding protein 1 ATP-dependent chromatin remodeling activity (27-28) HDAC5 histone deacetylase 5 Histone deacetylase activity (23,29,30) SETDB1 (ESET;KMT1E) SET domain, bifurcated 1 Histone-lysine N-methyltransferase activity (31-34) Transcription factors GTF3C2 general transcription factor IIIC, polypeptide 2, beta 110kDa Required for RNA polymerase III-mediated transcription HEYL (Hey3) hairy/enhancer-of-split related with YRPW motif-like DNA-binding transcription factor with basic helix-loop-helix domain (35) KLF10 (TIEG1) Kruppel-like factor 10 DNA-binding transcription factor with C2H2 zinc finger domain (36) NR2F1 (COUP-TFI) nuclear receptor subfamily 2, group F, member 1 DNA-binding transcription factor with C4 type zinc finger domain (ligand-regulated) (36) PEG3 paternally expressed 3 DNA-binding transcription factor with
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Proteomic Identification of the Transcription Factors Ikaros And
    European School of Molecular Medicine (SEMM) University of Milan and University of Naples “Federico II” PhD degree in Systems Medicine (curriculum in Molecular Oncology) Settore disciplinare: BIO/11 Proteomic identification of the transcription factors Ikaros and Aiolos as new Myc interactors on chromatin Chiara Veronica Locarno Matricola: R10755 Center for Genomic Science IIT@SEMM, Milan Supervisor: Bruno Amati, PhD IEO, Milan Added Supervisor: Arianna Sabò, PhD IEO, Milan Academic year 2017-2018 Table of contents List of abbreviations ........................................................................................................... 4 List of figures ....................................................................................................................... 8 List of tables ....................................................................................................................... 11 Abstract .............................................................................................................................. 12 1. INTRODUCTION ......................................................................................................... 13 1.1 Myc ........................................................................................................................................ 13 1.1.1 Myc discovery and structure ........................................................................................... 13 1.1.2. Role of Myc in physiological and pathological conditions ...........................................
    [Show full text]
  • Transcriptional Control of Tissue-Resident Memory T Cell Generation
    Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2019 © 2019 Filip Cvetkovski All rights reserved ABSTRACT Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Tissue-resident memory T cells (TRM) are a non-circulating subset of memory that are maintained at sites of pathogen entry and mediate optimal protection against reinfection. Lung TRM can be generated in response to respiratory infection or vaccination, however, the molecular pathways involved in CD4+TRM establishment have not been defined. Here, we performed transcriptional profiling of influenza-specific lung CD4+TRM following influenza infection to identify pathways implicated in CD4+TRM generation and homeostasis. Lung CD4+TRM displayed a unique transcriptional profile distinct from spleen memory, including up-regulation of a gene network induced by the transcription factor IRF4, a known regulator of effector T cell differentiation. In addition, the gene expression profile of lung CD4+TRM was enriched in gene sets previously described in tissue-resident regulatory T cells. Up-regulation of immunomodulatory molecules such as CTLA-4, PD-1, and ICOS, suggested a potential regulatory role for CD4+TRM in tissues. Using loss-of-function genetic experiments in mice, we demonstrate that IRF4 is required for the generation of lung-localized pathogen-specific effector CD4+T cells during acute influenza infection. Influenza-specific IRF4−/− T cells failed to fully express CD44, and maintained high levels of CD62L compared to wild type, suggesting a defect in complete differentiation into lung-tropic effector T cells.
    [Show full text]
  • Hepatitis C Virus As a Unique Human Model Disease to Define
    viruses Review Hepatitis C Virus as a Unique Human Model Disease to Define Differences in the Transcriptional Landscape of T Cells in Acute versus Chronic Infection David Wolski and Georg M. Lauer * Liver Center at the Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA * Correspondence: [email protected]; Tel.: +1-617-724-7515 Received: 27 June 2019; Accepted: 23 July 2019; Published: 26 July 2019 Abstract: The hepatitis C virus is unique among chronic viral infections in that an acute outcome with complete viral elimination is observed in a minority of infected patients. This unique feature allows direct comparison of successful immune responses with those that fail in the setting of the same human infection. Here we review how this scenario can be used to achieve better understanding of transcriptional regulation of T-cell differentiation. Specifically, we discuss results from a study comparing transcriptional profiles of hepatitis C virus (HCV)-specific CD8 T-cells during early HCV infection between patients that do and do not control and eliminate HCV. Identification of early gene expression differences in key T-cell differentiation molecules as well as clearly distinct transcriptional networks related to cell metabolism and nucleosomal regulation reveal novel insights into the development of exhausted and memory T-cells. With additional transcriptional studies of HCV-specific CD4 and CD8 T-cells in different stages of infection currently underway, we expect HCV infection to become a valuable model disease to study human immunity to viruses. Keywords: viral hepatitis; hepatitis C virus; T cells; transcriptional regulation; transcription factors; metabolism; nucleosome 1.
    [Show full text]
  • Accompanies CD8 T Cell Effector Function Global DNA Methylation
    Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function Christopher D. Scharer, Benjamin G. Barwick, Benjamin A. Youngblood, Rafi Ahmed and Jeremy M. Boss This information is current as of October 1, 2021. J Immunol 2013; 191:3419-3429; Prepublished online 16 August 2013; doi: 10.4049/jimmunol.1301395 http://www.jimmunol.org/content/191/6/3419 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2013/08/20/jimmunol.130139 Material 5.DC1 References This article cites 81 articles, 25 of which you can access for free at: http://www.jimmunol.org/content/191/6/3419.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 1, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function Christopher D. Scharer,* Benjamin G. Barwick,* Benjamin A. Youngblood,*,† Rafi Ahmed,*,† and Jeremy M.
    [Show full text]
  • Development and Validation of a Novel Immune-Related Prognostic Model
    Wang et al. J Transl Med (2020) 18:67 https://doi.org/10.1186/s12967-020-02255-6 Journal of Translational Medicine RESEARCH Open Access Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma Zheng Wang1, Jie Zhu1, Yongjuan Liu3, Changhong Liu2, Wenqi Wang2, Fengzhe Chen1* and Lixian Ma1* Abstract Background: Growing evidence has suggested that immune-related genes play crucial roles in the development and progression of hepatocellular carcinoma (HCC). Nevertheless, the utility of immune-related genes for evaluating the prognosis of HCC patients are still lacking. The study aimed to explore gene signatures and prognostic values of immune-related genes in HCC. Methods: We comprehensively integrated gene expression data acquired from 374 HCC and 50 normal tissues in The Cancer Genome Atlas (TCGA). Diferentially expressed genes (DEGs) analysis and univariate Cox regression analysis were performed to identify DEGs that related to overall survival. An immune prognostic model was constructed using the Lasso and multivariate Cox regression analyses. Furthermore, Cox regression analysis was applied to identify independent prognostic factors in HCC. The correlation analysis between immune-related signature and immune cells infltration were also investigated. Finally, the signature was validated in an external independent dataset. Results: A total of 329 diferentially expressed immune‐related genes were detected. 64 immune‐related genes were identifed to be markedly related to overall survival in HCC patients using univariate Cox regression analysis. Then we established a TF-mediated network for exploring the regulatory mechanisms of these genes. Lasso and multivariate Cox regression analyses were applied to construct the immune-based prognostic model, which consisted of nine immune‐related genes.
    [Show full text]
  • Construction of a Cerna Network Combining Transcription Factors in Eutopic Endometrial Tissue of Tubal Factor Infertility and Endometriosis-Related Infertility
    Construction of a ceRNA network combining transcription factors in eutopic endometrial tissue of tubal factor infertility and endometriosis-related infertility Junzui Li ( [email protected] ) Xiamen University https://orcid.org/0000-0002-6640-8215 Lulu Ren Xiamen University Medical College Cui Yang Xiamen University Medical College Rongfeng Wu Xiamen University Medical College Zhixiong Huang Xiamen University School of Life Sciences Qionghua Chen Xiamen University Medical College Research article Keywords: TFI, endometriosis-related infertility, DEGs, ceRNA network, TFs Posted Date: December 19th, 2019 DOI: https://doi.org/10.21203/rs.2.19312/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/27 Abstract Purpose Although tubal factor infertility (TFI) and endometriosis-related infertility all can result in female infertility, the pathogenesis of TFI and endometriosis-related infertility were different. The pathophysiologic mechanisms of TFI and endometriosis-related infertility have not been investigated thoroughly. Thus, the aim of the study is to identify the potential crucial genes, pathways, transcription factors (TFs) and long non-coding RNAs (lncRNAs) associated with TFI and endometriosis-related infertility, and further analyze the molecular mechanism implicated in genes. Methods 3 patients with TFI and 3 patients with endometriosis-related infertility were recruited, and microarray hybridization of the eutopic endometrial tissue during the window of implantation (WOI) was performed to examine the expression of mRNAs and lncRNAs. First, differentially expressed genes (DEGs) and differentially expressed lncRNAs (DELs) were screened out based on P < 0.05 and fold change (FC) ≧ 2. Second, gene ontology, pathway and TFs enrichment analyses and PPI network construction of DEGs were performed.
    [Show full text]
  • 1714 Gene Comprehensive Cancer Panel Enriched for Clinically Actionable Genes with Additional Biologically Relevant Genes 400-500X Average Coverage on Tumor
    xO GENE PANEL 1714 gene comprehensive cancer panel enriched for clinically actionable genes with additional biologically relevant genes 400-500x average coverage on tumor Genes A-C Genes D-F Genes G-I Genes J-L AATK ATAD2B BTG1 CDH7 CREM DACH1 EPHA1 FES G6PC3 HGF IL18RAP JADE1 LMO1 ABCA1 ATF1 BTG2 CDK1 CRHR1 DACH2 EPHA2 FEV G6PD HIF1A IL1R1 JAK1 LMO2 ABCB1 ATM BTG3 CDK10 CRK DAXX EPHA3 FGF1 GAB1 HIF1AN IL1R2 JAK2 LMO7 ABCB11 ATR BTK CDK11A CRKL DBH EPHA4 FGF10 GAB2 HIST1H1E IL1RAP JAK3 LMTK2 ABCB4 ATRX BTRC CDK11B CRLF2 DCC EPHA5 FGF11 GABPA HIST1H3B IL20RA JARID2 LMTK3 ABCC1 AURKA BUB1 CDK12 CRTC1 DCUN1D1 EPHA6 FGF12 GALNT12 HIST1H4E IL20RB JAZF1 LPHN2 ABCC2 AURKB BUB1B CDK13 CRTC2 DCUN1D2 EPHA7 FGF13 GATA1 HLA-A IL21R JMJD1C LPHN3 ABCG1 AURKC BUB3 CDK14 CRTC3 DDB2 EPHA8 FGF14 GATA2 HLA-B IL22RA1 JMJD4 LPP ABCG2 AXIN1 C11orf30 CDK15 CSF1 DDIT3 EPHB1 FGF16 GATA3 HLF IL22RA2 JMJD6 LRP1B ABI1 AXIN2 CACNA1C CDK16 CSF1R DDR1 EPHB2 FGF17 GATA5 HLTF IL23R JMJD7 LRP5 ABL1 AXL CACNA1S CDK17 CSF2RA DDR2 EPHB3 FGF18 GATA6 HMGA1 IL2RA JMJD8 LRP6 ABL2 B2M CACNB2 CDK18 CSF2RB DDX3X EPHB4 FGF19 GDNF HMGA2 IL2RB JUN LRRK2 ACE BABAM1 CADM2 CDK19 CSF3R DDX5 EPHB6 FGF2 GFI1 HMGCR IL2RG JUNB LSM1 ACSL6 BACH1 CALR CDK2 CSK DDX6 EPOR FGF20 GFI1B HNF1A IL3 JUND LTK ACTA2 BACH2 CAMTA1 CDK20 CSNK1D DEK ERBB2 FGF21 GFRA4 HNF1B IL3RA JUP LYL1 ACTC1 BAG4 CAPRIN2 CDK3 CSNK1E DHFR ERBB3 FGF22 GGCX HNRNPA3 IL4R KAT2A LYN ACVR1 BAI3 CARD10 CDK4 CTCF DHH ERBB4 FGF23 GHR HOXA10 IL5RA KAT2B LZTR1 ACVR1B BAP1 CARD11 CDK5 CTCFL DIAPH1 ERCC1 FGF3 GID4 HOXA11 IL6R KAT5 ACVR2A
    [Show full text]
  • Blimp1-Mediated Repression of Negative Regulators Is Required for Osteoclast Differentiation
    Blimp1-mediated repression of negative regulators is required for osteoclast differentiation Keizo Nishikawaa,b, Tomoki Nakashimaa,b,c, Mikihito Hayashia,b, Takanobu Fukunagaa,b, Shigeaki Katod,e, Tatsuhiko Kodamaf, Satoru Takahashig, Kathryn Calameh, and Hiroshi Takayanagia,b,c,1 aDepartment of Cell Signaling, Tokyo Medical and Dental University, Tokyo 113-8549, Japan; bGlobal Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo 113-8549, Japan; cTakayanagi Osteonetwork Project, Exploratory Research for Advanced Technology, Japan Science and Technology Agency, Tokyo 113-8549, Japan; dInstitute of Molecular and Cellular Biosciences, Graduate School of Medicine, University of Tokyo, Tokyo 113-0032, Japan; eKato Nuclear Complex, Exploratory Research for Advanced Technology, Japan Science and Technology Agency, Saitama 332-0012, Japan; fResearch Center for Advanced Science and Technology, Department of Molecular Biology and Medicine, University of Tokyo, Tokyo 153-8904, Japan; gInstitute of Basic Medical Sciences and Laboratory Animal Resource Center, University of Tsukuba, Tsukuba 305-8575, Japan; and hDepartment of Biochemistry and Molecular Biophysics, Columbia University College of Physicians and Surgeons, New York, NY 10032 Edited by Anjana Rao, Harvard Medical School, Boston, MA, and approved December 23, 2009 (received for review November 7, 2009) Regulation of irreversible cell lineage commitment depends on a own promoter in cooperation with c-Fos (12). This autoampli-
    [Show full text]
  • Lhx2 Regulates Bone Remodeling in Mice by Modulating RANKL Signaling in Osteoclasts
    Cell Death and Differentiation (2014) 21, 1613–1621 & 2014 Macmillan Publishers Limited All rights reserved 1350-9047/14 www.nature.com/cdd Lhx2 regulates bone remodeling in mice by modulating RANKL signaling in osteoclasts JH Kim1,2,3, BU Youn1,2, K Kim1,2, JB Moon1,2, J Lee1,2, K-Il Nam4, Y-W Park5, DDM O’Leary6, KK Kim1,2,3 and N Kim*,1,2,3 The LIM homeobox 2 (Lhx2) transcription factor Lhx2 has a variety of functions, including neural induction, morphogenesis, and hematopoiesis. Here we show the involvement of Lhx2 in osteoclast differentiation. Lhx2 was strongly expressed in osteoclast precursor cells but its expression was significantly reduced during receptor activator of nuclear factor-jB ligand (RANKL)- mediated osteoclastogenesis. Overexpression of Lhx2 in bone marrow-derived monocyte/macrophage lineage cells (BMMs), which are osteoclast precursor cells, attenuated RANKL-induced osteoclast differentiation by inhibiting the induction of nuclear factor of activated T cells c1 (NFATc1). Interestingly, interaction of Lhx2 proteins with c-Fos attenuated the DNA-binding ability of c-Fos and thereby inhibited the transactivation of NFATc1. Furthermore, Lhx2 conditional knockout mice exhibited an osteoporotic bone phenotype, which was related with increased osteoclast formation in vivo. Taken together, our results suggest that Lhx2 acts as a negative regulator of osteoclast formation in vitro and in vivo. The anti-osteoclastogenic effect of Lhx2 may be useful for developing a therapeutic strategy for bone disease. Cell Death and Differentiation (2014) 21, 1613–1621; doi:10.1038/cdd.2014.71; published online 6 June 2014 Bone homeostasis is maintained by a delicate balance PU.1, and nuclear factor of activated T cells c1 (NFATc1), between the activities of osteoblasts and those of osteoclasts.
    [Show full text]
  • Factor Nfatc2 Responses in Mice Lacking the Transcription Impaired
    Impaired Mast Cell-Driven Immune Responses in Mice Lacking the Transcription Factor NFATc2 This information is current as Marc Becker, Valeska Heib, Matthias Klein, Fatma Doener, of September 24, 2021. Tobias Bopp, Christian Taube, Markus Radsak, Hansjörg Schild, Edgar Schmitt and Michael Stassen J Immunol 2009; 182:6136-6142; ; doi: 10.4049/jimmunol.0802878 http://www.jimmunol.org/content/182/10/6136 Downloaded from References This article cites 33 articles, 13 of which you can access for free at: http://www.jimmunol.org/content/182/10/6136.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 24, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Impaired Mast Cell-Driven Immune Responses in Mice Lacking the Transcription Factor NFATc21 Marc Becker,* Valeska Heib,† Matthias Klein,* Fatma Doener,* Tobias Bopp,* Christian Taube,‡ Markus Radsak,‡ Hansjo¨rg Schild,* Edgar Schmitt,* and Michael Stassen2* The three calcium-dependent factors NFATc1, c2, and c3 are expressed in cells of the immune system and play pivotal roles in modulating cellular activation.
    [Show full text]